Revolution Medicines (NASDAQ: RVMD) Price Target Jumps to $260 After RASONQUE FDA Approval
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameRevolution Medicines Inc
-
Registration countryUSA
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









